Kurt Gustafson | Executive Vice President, Chief Financial Officer and Principal Accounting Officer |
Joseph Turgeon | President and Chief Executive Officer |
Thomas Riga | Chief Operating Officer |
Adnan Butt | Guggenheim Securities |
Matthew Andrews | Jefferies LLC |
Good day, ladies and gentlemen, and welcome to Spectrum Pharmaceuticals second quarter 2018 financial results conference call. At this time, all participants are in a listen-only mode. [Operator Instructions]. Also, as a reminder, today's conference is being recorded. I would now like to turn the conference over to Spectrum Pharmaceuticals' Chief Financial Officer Kurt Gustafson.